.OS Therapies will certainly list on the NYSE American supply substitution this morning via a $6.4 t...
.ALX Oncology's period 2 gastric cancer action fee has weakened. After observing its CD47 blocker ef...
.Another of Ionis Pharmaceuticals' key midphase readouts has disappointed requirements, urging the b...
.While Biogen's pharma peers are seeking for late-stage assets with little bit of danger, chief exec...
.Instil Biography has been a biotech seeking a pipeline after it scrapped its lead resources over th...
.Biogen has restored civil rights to an early Alzheimer's condition system to Denali Therapeutics, g...
.Invite to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings as...
.Tip's attempt to handle an unusual hereditary disease has actually struck yet another misfortune. T...
.Vir Medical's second-quarter earnings record had not been except huge news. The firm welcomed a tri...
.Galapagos has actually paused enrollment in a trial of a BCMA-directed CAR-T cell therapy, pumping ...